Get started
Author

Diane Corriveau

Observed name: D. Corriveau
Observed institution: GlaxoSmithKline (Canada)
OpenAlex ID: A5073607352
Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients
2014 · A. Ismaila, D. Corriveau, et al. · Current Medical Research and Opinion · 45
Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients
2014 · A. Ismaila, D. Corriveau, et al. · Current Medical Research and Opinion · 42
COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada
2014 · Afisi S. Ismaila, Nancy Risebrough, et al. · Respiratory Medicine · 17
PDF
The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada
2017 · Tam Dang-Tan, Shiyuan Zhang, et al. · Canadian Respiratory Journal · 8
PDF
Direct and indirect costs associated with moderate and severe asthma in Quebec, Canada
2019 · Afisi Ismaila, Lucie Blais, et al. · Canadian Journal of Respiratory Critical Care and Sleep Medicine · 5
Impact of adherence to treatment with tiotropium co-administered with fluticasone propionate/salmeterol combination in COPD patients
2013 · Afisi Ismaila, John Sampalis, et al. · European Respiratory Journal · 1
Impact of adherence to fluticasone propionate/salmeterol combination (FSC) therapy on the outcomes of patients with asthma: A population based study
2013 · Afisi Ismaila, John Sampalis, et al. · European Respiratory Journal
Works count: 7
Citation count: 118
H-index: 5
I10-index: 3
Year
Topic
Type